Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors (Q3300939): Difference between revisions
Jump to navigation
Jump to search
(BatchIngestion) |
(Added qualifier: readability score (P590521): 0.000011549099478063191) |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / instance of: Kohesio project / rank | Property / instance of: Kohesio project / rank | ||||||||||||||
Deprecated rank | |||||||||||||||
| Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549099478063191
| |||||||||||||||
| Property / instance of | |||||||||||||||
| Property / instance of: Discontinued Kohesio Project / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
16 February 2024
| |||||||||||||||
| Property / date of last update: 16 February 2024 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:01, 23 March 2024
Project Q3300939 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors |
Project Q3300939 in Germany |
Statements
374,380.01 Euro
0 references
467,975.01 Euro
0 references
80.0 percent
0 references
1 October 2020
0 references
30 September 2022
0 references
AmpliVak Immunotherapy GmbH
0 references
52°38'15.29"N, 13°12'20.70"E
0 references
Hennigsdorf, Stadt
0 references
16 February 2024
0 references
Identifiers
DE_TEMPORARY_3741
0 references